Managing Patients Taking a CDK4/6 Inhibitor
You are cordially invited to attend an educational speaker program:
Managing Patients Taking a CDK4/6 Inhibitor for the First-Line Treatment of HR+/HER2- Advanced Breast Cancer (T-BST-1152085)
Howard Levine, PharmD
Director of Pharmacy, Queens Medical Associates NY
Howard L Levine Consulting, Inc.
RSVP by 3/12/18